Drugs / MNK6106
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03712280 | Dec 2018 → Jul 2020 | cirrhosis of liver, hepatic encephalopathy | Mallinckrodt | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MNK6106 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03712280 ↗ |
| Route | Oral | “1 gram tablet of MNK6106 for oral administration” NCT03712280 ↗ |